Spatio-temporal variation and sensitivity analysis of aerosol particulate matter during the COVID-19 phase-wise lockdowns in Indian cities.

At the pandemic of COVID-19, the movement of business and other non-essential activities were majorly restricted at the end of March 2020 in India and continued in different lockdown phases until June 2020. By categorically, studying sensitivity towards anthropogenic factors with other environmental implications in urban Indian cities during phase-wise lockdown scenarios will pave the way for a refined Clean Air Programme (CAP). In this study, the aerosol particulate matter variations between the lockdown phases in both spatial and temporal scales have been explored along with cities exceeding national ambient air quality (NAAQ) standards covering different geographical regions of India for their air quality level. The results of the spatial pattern of Copernicus Atmosphere Monitoring System (CAMS) near-real-time data showed a negative change both in Aerosol Optical Depth (AOD) (-0.2 to 0.1) and black carbon AOD (bcAOD) (-0.9 to -0.75). The changes were evident in successive phases of lockdown with an overall AOD reduction of about 70-90%. Southern urban cities showed a significant impact of mobile sources from temporal analysis than other cities. Principal Component Analysis (PCA) for effects of pollutants by anthropogenic factors (mobile and point source) and meteorological factors (wind speed, wind direction, solar radiation, relative humidity) revealed the two significant driving factors. PM reduction was about 50-70%, predominantly due to anthropogenic factors. The factor analysis revealed the influence of meteorological factors between the major urban cities (Delhi, Kolkata, Mumbai, Chennai, Bengaluru, and Hyderabad). Cities that exceed NAAQ standard performed well during phase-wise lockdowns, exceptional to cities in Gangetic plain. This study helps to frame region-specific strategic action plans for the CAP.

Morphometric studies of rat anterior pituitary cells after gonadectomy: correlation of changes in gonadotropes with the serum levels of gonadotropins.

Anterior pituitary cells were studied with immunocytochemical methods 1-6 months after gonadectomy in male and female rats. One month after surgery, stained gonadotropes contained small scattered cisternae of rough endoplasmic reticulum, while others showed larger cisternae. The signet ring cells were observed 3 months after gonadectomy, and their numbers increased markedly by 6 months. Counts of freshly dispersed stained cells showed that in intact rats, the only significant sex differences were seen in the percentages of FSH and PRL cells. The females had higher percentages of both cell types. One month after castration, there were 2- and 3-fold increases in the percentages of LH and FSH cells, respectively. In females, ovariectomy resulted in a 2-fold increase in the percentage of LH cells and a slight but not significant increase in that of FSH cells. Three months after surgery, the percentages of LH or FSH gonadotropes increased from 8-12% to about 30% in both sexes. In the 6-month group, the percentages of stained gonadotropes were decreased to about 20% in both males and females. Counts of other pituitary cell types showed that the percentage of PRL cells in females declined to levels similar to those in the male within 1 month after ovariectomy. There was also a significant increase in the percentage of GH cells 1-3 months after ovariectomy. In contrast, the percentages of GH-producing cells decreased in the castrated males 3-6 months after surgery. The other pituitary cell types (ACTH and TSH) did not show significant changes after gonadectomy in either sex. The average area of gonadotropes was increased gradually, reaching a maximum 3 months after gonadectomy, after which it was decreased in the 6-month group. After ovariectomy, serum levels of gonadotropins correlated well with changes in areas of gonadotropes, showing a continuous increase until the third month, followed by a decrease after 6 months. Serum LH levels increased and then decreased after castration following the same pattern as that of the average areas. However, serum FSH levels continued to increase gradually throughout the entire 6 months. These studies are the first to quantify changes in all six pituitary cell types after gonadectomy. The counts confirm qualitative data reported previously that show changes in GH and PRL cells after gonadectomy (including sex differences). We extend previous studies that show that the expansion in gonadotropic cell area is correlated with a rise in both serum LH and FSH.

Tenascin expression in prostatic hyperplasia, intraepithelial neoplasia, and carcinoma.

The expression of tenascin, an extracellular matrix glycoprotein, was studied in three human prostatic carcinoma cell lines by Northern and Western blot analyses and in human prostate tissues by immunohistochemistry and Western blot analysis. All three carcinoma cell lines expressed tenascin mRNA and protein, which were found predominantly in secreted form in culture supernatant. By immunohistochemistry, fetal prostatic tissue showed strong and diffuse tenascin immunoreactivity around developing glands. Normal adult prostatic tissue revealed only focal, scant periglandular and stromal immunoreactivity around acini and ducts. Most cases of hyperplasia and intraepithelial neoplasia showed variable periglandular immunostaining. Tenascin periglandular staining with diffuse stromal extension was noted with all grades of adenocarcinoma; however, the intensity was variable and appeared unrelated to the histologic grade. Metastatic prostatic carcinoma showed strong immunoreactivity in lymph nodes and bone marrow samples, with only weak reactivity of the normal connective tissue framework in both tissues. Western blot analysis of prostatic hyperplasia and carcinoma demonstrated the large and small isoforms of tenascin. These findings suggest a prominent role for tenascin in stromal alterations associated with both benign and malignant prostatic epithelial growth processes.

Prospective correlation of cervicovaginal cytologic and histologic specimens.

An effective, prospective, computer-guided method of correlation is reported. The mechanism for identification of cases, comparison of diagnoses, and reconciliation of discrepancies are explained. The results are similar to prior, retrospective, correlation studies. The benefits specific to this unique prospective approach include optimal capture of cases for correlation, minimization of errors before diagnoses are released to clinicians and patients, and internal standardization of diagnostic criteria. Three thousand four hundred and four consecutive paired cervicovaginal cytologies and biopsies were accessioned at the Pathology Department of Duke University Medical Center over a 43-month period. Of these, 481 paired cases (14%) had discordant diagnoses, defined as differing more than one degree of dysplasia or as dysplasia or carcinoma identified by only one modality. Additional evaluation reconciled the diagnostic differences in 35 cases. Eighteen initial diagnostic differences arose from cytologic screening errors, 16 from interpretive errors by staff pathologists, and one from superficial initial histologic sections. The remaining 446 discordances were attributed to sampling differences. The cytologic smear contained the diagnostic lesion in 40% of the cases and the biopsy the remainder, emphasizing the utility of pairing these sampling techniques in patients at risk for dysplasia.

Differential immunoreactivity of her-2/neu oncoprotein in prostatic tissues.

To investigate HER-2/neu oncoprotein immunoreactivity, monoclonal antibody TA1 immunohistochemical examination of flash-frozen radical prostatectomy specimens was performed (n = 35). All prostatic specimens contained benign prostatic hyperplasia (BPH) and/or prostatic intraepithelial neoplasia (PIN), as well as prostatic carcinoma (CaP). HER-2/neu oncoprotein immunoreactivity in BPH tissues was not significantly different than that for the PIN basal cell layer (P = 0.10) or for the PIN luminal cells (P = 0.17). There was significantly more HER-2/neu oncoprotein immunoreactivity in BPH than in areas of CaP (P < 0.001). There was no significant difference in the amount of immunoreactivity present in PIN basal cells when compared to the PIN luminal cells (P = 0.49). Both the PIN basal cells and luminal cells stained for the HER-2/neu oncoprotein to a higher degree than cells in the CaP areas (P < 0.001 in both cases). HER-2/neu oncoprotein immunoreactivity is present at a significantly higher degree in BPH and PIN than in malignant prostatic epithelium.

Detection of human papillomavirus in the prostate by polymerase chain reaction and in situ hybridization.

Human papillomavirus is associated with a variety of anogenital lesions, including genital warts, precancers and cancers. In male patients human papillomavirus has been identified in proliferative lesions ranging from penile and urethral warts to penile and prostatic cancers. We examined the association of human papillomavirus deoxyribonucleic acid (DNA) in 84 prostate tissue specimens. Specimens were selected from radical prostatectomy, transurethral resection or transrectal biopsy procedures. A total of 60 formalin-fixed, paraffin-embedded tissues (24 prostate cancer specimens, 16 benign prostatic hyperplasia specimens and 20 normal specimens) was examined by polymerase chain reaction and in situ hybridization. Also, 24 gelatin-embedded frozen prostate cancer specimens were examined for human papillomavirus DNA by polymerase chain reaction. Of the specimens 69 were deemed adequate for polymerase chain reaction analysis, whereas all 60 paraffin-embedded tissues were sufficient for in situ hybridization. Human papillomavirus DNA was detected in 2 normal tissues and 6 prostate cancers using polymerase chain reaction. None of the benign prostatic hyperplasia specimens was positive for human papillomavirus. Human papillomavirus typing results indicated that virus type 16 was present in each of the 8 positive specimens. Confirmation of the presence of human papillomavirus was obtained for 1 of the prostate cancers by nonisotopic in situ hybridization with biotinylated human papillomavirus genomic probes. The low prevalence of human papillomavirus in this study population does not strongly support an etiological role for the virus in prostate cancer.

Differential immunoreactivity of epidermal growth factor receptor in benign, dysplastic and malignant prostatic tissues.

To investigate epidermal growth factor receptor (EGFr) presence in the prostate, monoclonal antibody (clone EGFR1) immunohistochemical examination of radical prostatectomy specimens was performed (n = 37). All prostatic specimens contained benign prostatic hyperplasia (BPH) and/or dysplasia (prostatic intraepithelial neoplasia or PIN), as well as prostatic carcinoma (CaP). Areas of dysplasia were further categorized as to the basal cell layer and the luminal cell area. BPH, PIN, and CaP tissues in each specimen were analyzed by a single observer and graded on a scale from 0-4+. Fifteen samples were also analyzed for EGFr content utilizing a Cell Analysis Systems (CAS 200) image cytometer. EGFr immunoreactivity of BPH basal cells was significantly higher than EGFr immunoreactivity in areas of CaP (p < 0.001). EGFr staining of BPH basal cells was also significantly higher than that seen in PIN luminal cells (p < 0.001). Immunoreactivity of EGFr in PIN basal cells was significantly higher than in PIN luminal cells (p < 0.001). EGFr staining of basal cells in BPH tissues was higher than that seen in the PIN basal cell layer but the difference was not statistically significant (p = 0.06). The amount of staining present in PIN luminal cells was also significantly greater than in CaP tissues (p = 0.002). Quantitative image analysis utilizing the CAS 200 image cytometer was performed on BPH and CaP areas exclusively. EGFr immunoreactivity in basal cells of the BPH tissues was significantly greater than that seen in CaP tissues (p < 0.001). The decreased EGFr immunoreactivity in CaP may reflect a differentiating role for EGFr in normal tissues. Loss of EGFr influence may be associated with an increased proliferative state in PIN and CaP. Destruction or alteration of the epidermal grwoth factor receptor by a protease, such as prostatic specific antigen, may also explain our findings. At the present time the meaning of the different amounts of EGFr in the various types of prostate tissues is unknown.